- Which of the following patterns of renin secretion is expected in this patient?
Answer: Markedly elevated renin from the left renal vein and suppressed renin from the right renal vein.
The correct answer is A. The stenosis in the left renal artery causes profound hypoperfusion of the left kidney. The juxtaglomerular apparatus of the left kidney interprets this as systemic hypotension and dramatically increases renin secretion. This high level of renin enters the systemic circulation, activating the RAAS and causing severe hypertension. The healthy right kidney is exposed to this high systemic blood pressure, which, along with high levels of angiotensin II, provides strong negative feedback to its juxtaglomerular cells, suppressing its renin release.
- Which of the following conditions best explains this constellation of findings?
Answer: Liddle syndrome, due to a gain-of-function mutation in the epithelial sodium channel (ENaC).
The correct answer is A. Liddle syndrome is a rare genetic disorder causing a gain-of-function mutation in the ENaC in the collecting ducts. This leads to excessive sodium reabsorption and potassium secretion, mimicking hyperaldosteronism. However, because the process is independent of aldosterone, the resulting volume expansion and hypertension suppress both renin and aldosterone production. The clinical picture is therefore one of apparent mineralocorticoid excess with low aldosterone levels.
- Angiotensin II exerts its effects on sodium balance through multiple mechanisms. Besides stimulating aldosterone secretion, what is a direct effect of angiotensin II on the renal tubules?
Answer: It directly stimulates the Na+/H+ exchanger in the proximal convoluted tubule.
The correct answer is A. Angiotensin II has a direct, aldosterone-independent effect on the proximal convoluted tubule. It stimulates the Na+/H+ exchanger (NHE3) on the apical membrane and the Na+/K+ ATPase and Na+/HCO3- cotransporter on the basolateral membrane. The net effect is a significant increase in the reabsorption of sodium and bicarbonate from the proximal tubular fluid, contributing to volume preservation.
- The integration of the baroreceptor reflex and the RAAS is essential for blood pressure homeostasis. Following a sudden, severe hemorrhage, which of the following represents the most rapid compensatory vasoconstrictor response?
Answer: Increased norepinephrine release from sympathetic nerve terminals.
The correct answer is C. The baroreceptor reflex is the body's fastest mechanism for responding to changes in blood pressure. A drop in pressure, as seen in hemorrhage, is sensed by baroreceptors in the carotid sinus and aortic arch. This leads to a near-instantaneous increase in sympathetic outflow from the brainstem. The release of norepinephrine at vascular smooth muscle nerve endings causes rapid, widespread vasoconstriction to increase total peripheral resistance and support blood pressure within seconds.
- During a normal third-trimester pregnancy, plasma volume is expanded by 40-50%, cardiac output is increased, yet systemic vascular resistance and blood pressure are typically lower than pre-pregnancy levels. Which of the following best describes the state of the renin-angiotensin-aldosterone system (RAAS) during this time?
Answer: The RAAS is highly activated, but the vasculature is refractory to the pressor effects of angiotensin II.
The correct answer is B. Pregnancy presents a physiological paradox for the RAAS. Estrogen increases hepatic synthesis of angiotensinogen, and the placenta produces renin. These factors, combined with systemic vasodilation (caused by progesterone and other vasodilators), lead to a massive activation of the RAAS, with very high levels of renin, angiotensin II, and aldosterone. This is necessary to promote the volume retention required for pregnancy. However, the maternal vasculature develops a refractoriness or resistance to the vasoconstrictive effects of angiotensin II, which is why blood pressure does not rise and often falls.
- A patient with nephrotic syndrome presents with massive proteinuria, hypoalbuminemia, and generalized edema. Their blood pressure is 100/60 mmHg. Which statement most accurately describes the role of the RAAS in this patient's edema formation?
Answer: RAAS is activated due to decreased effective circulating volume, driving primary renal sodium retention.
When you encounter nephrotic syndrome questions, focus on the concept of effective circulating volume versus total body fluid volume—these can move in opposite directions and drive different physiological responses.
In nephrotic syndrome, massive protein loss creates hypoalbuminemia, which reduces plasma oncotic pressure. This allows fluid to shift from the intravascular space into the interstitium, causing edema. Critically, this fluid shift reduces the effective circulating volume (the portion of blood volume that effectively perfuses organs), even though total body fluid is increased. The low blood pressure (100/60 mmHg) confirms reduced effective circulation.
The kidneys respond to this decreased effective circulating volume by activating RAAS, which promotes sodium and water retention to restore intravascular volume. However, because the underlying problem (low albumin) persists, this retained fluid also leaks into tissues, worsening edema while the kidneys continue sensing volume depletion.
Answer D correctly identifies this mechanism—RAAS activation due to decreased effective circulating volume driving primary renal sodium retention. Answer A is wrong because RAAS responds to effective circulating volume, not total body volume overload. Answer B incorrectly suggests RAAS plays no role when it's actually a major contributor to the sodium retention that perpetuates edema. Answer C oversimplifies by attributing RAAS activation solely to renal ischemia, missing the primary mechanism of reduced effective circulation.
Study tip: Remember that in edematous states, always distinguish between total body fluid (often increased) and effective circulating volume (often decreased)—the kidneys respond to the latter.
- The macula densa cells of the juxtaglomerular apparatus initiate the process of renin release. What specific signal is primarily sensed by these cells to trigger this cascade?
Answer: Decreased chloride concentration in the tubular fluid.
When you encounter questions about the juxtaglomerular apparatus and renin release, focus on the specific monitoring functions of each cell type. The macula densa cells act as sodium chloride sensors that detect changes in tubular fluid composition flowing past them in the distal convoluted tubule.
The macula densa cells primarily respond to decreased sodium chloride concentration in the tubular fluid. When these cells detect low NaCl levels (specifically low chloride), they interpret this as reduced effective circulating volume or decreased glomerular filtration rate. This triggers them to stimulate renin release from the adjacent juxtaglomerular cells, initiating the renin-angiotensin-aldosterone system to restore blood pressure and volume.
Looking at the incorrect options: A) is wrong because macula densa cells don't sense hydrostatic pressure—that's the role of baroreceptors in the afferent arteriole walls. B) is incorrect because these cells monitor tubular fluid composition, not blood osmolarity in the arterioles. C) is wrong because macula densa cells specifically sense sodium chloride, not potassium secretion, which occurs downstream in the collecting duct via principal cells.
The key distinction is that answer D correctly identifies chloride as the specific ion sensed, while the other options either reference the wrong sensing mechanism or wrong anatomical location.
Study tip: Remember that the juxtaglomerular apparatus has specialized cells for different functions: macula densa cells = NaCl sensors in tubular fluid, juxtaglomerular cells = renin producers, and mesangial cells = structural support. Each responds to different stimuli in the renin release pathway.
- In addition to angiotensin II, which of the following is a potent direct stimulator of aldosterone secretion from the zona glomerulosa of the adrenal cortex?
Answer: A high concentration of plasma potassium.
When you encounter questions about aldosterone regulation, focus on the hormone's primary function: maintaining electrolyte balance and blood pressure. The zona glomerulosa responds to specific stimuli that signal the need for sodium retention and potassium excretion.
Elevated plasma potassium concentration is indeed a potent direct stimulator of aldosterone secretion. When potassium levels rise, the zona glomerulosa cells depolarize, triggering calcium influx and aldosterone synthesis. This makes biological sense—aldosterone promotes potassium excretion through the kidneys, so high potassium directly signals the need for this hormone.
Let's examine why the other options are incorrect:
A) High plasma sodium concentration actually inhibits aldosterone secretion. Since aldosterone promotes sodium retention, elevated sodium levels signal that aldosterone is not needed.
B) Atrial natriuretic peptide (ANP) directly suppresses aldosterone production. ANP is released when blood volume is high and works to decrease sodium retention—the opposite effect of aldosterone.
C) While ACTH can stimulate aldosterone secretion, it's not considered a major physiological regulator. ACTH primarily controls cortisol from the zona fasciculata, with only minor effects on aldosterone under normal conditions.
Remember the "big three" stimulators of aldosterone: angiotensin II (mentioned in the question), high potassium, and low sodium. When studying the renin-angiotensin-aldosterone system, always consider both the hormonal cascade (angiotensin II) and the direct electrolyte effects (potassium and sodium) on aldosterone secretion.
- Which of the following is the primary pathophysiological mechanism responsible for the hyponatremia observed in this patient?
Answer: Non-osmotic release of antidiuretic hormone (ADH) leading to impaired free water excretion.
The correct answer is C. In decompensated heart failure, low cardiac output leads to decreased effective circulating volume. This is sensed by baroreceptors, triggering potent non-osmotic stimuli for ADH release (via carotid sinus and aortic arch reflexes) and activating the RAAS. Angiotensin II also stimulates ADH release. The elevated ADH increases water reabsorption in the collecting ducts, leading to a dilutional hyponatremia because water is retained in excess of sodium.
- A patient is given an experimental drug that selectively and potently blocks the AT2 receptor, leaving the AT1 receptor unaffected. What is the most likely physiological consequence of administering this drug?
Answer: An unopposed, exaggerated effect of AT1 receptor stimulation, such as increased vasoconstriction.
When you encounter questions about selective receptor blockade, think about the balance between opposing receptor subtypes and what happens when you tip that balance.
The renin-angiotensin system has two main receptor types with opposing effects. AT1 receptors mediate the "bad" effects of angiotensin II: vasoconstriction, aldosterone release, and sodium retention. AT2 receptors generally oppose these actions, promoting vasodilation, natriuresis, and anti-proliferative effects. These receptors normally work in balance to modulate angiotensin II's overall impact.
By selectively blocking AT2 receptors while leaving AT1 receptors intact, you remove the counterbalancing effects. Now angiotensin II can only bind to AT1 receptors, creating an unopposed, exaggerated response. This means enhanced vasoconstriction, increased aldosterone release, and greater sodium retention - essentially amplifying all the harmful cardiovascular effects. Answer D correctly identifies this unopposed AT1 stimulation.
Answer A is backwards - blocking the protective AT2 receptors would increase blood pressure and reduce natriuresis. Answer B misunderstands the receptor roles; AT2 blockade wouldn't inhibit aldosterone (that's an AT1 effect) but would actually allow more aldosterone release. Answer C incorrectly assumes AT2 blockade mimics ACE inhibition, when it actually does the opposite - ACE inhibitors reduce angiotensin II formation, while AT2 blockade shifts existing angiotensin II toward harmful AT1 effects.
Remember: when studying receptor systems, always consider whether receptors work synergistically or antagonistically. Blocking one member of an antagonistic pair amplifies the other's effects.
- In a state of significant hypovolemia, such as after a hemorrhage, what is the net effect of the resultant high levels of angiotensin II on the glomerular filtration rate (GFR)?
Answer: GFR is preferentially maintained due to greater vasoconstriction of the efferent arteriole compared to the afferent arteriole.
The correct answer is B. Angiotensin II is a potent vasoconstrictor of both the afferent and efferent glomerular arterioles. However, its effect is much more pronounced on the efferent arteriole. This differential constriction increases the hydrostatic pressure within the glomerular capillaries, which counteracts the tendency for GFR to fall due to the decreased renal blood flow from hypovolemia. This mechanism is a critical adaptation to preserve renal function during states of low perfusion.
- A patient switches from an ACE inhibitor (lisinopril) to an angiotensin II receptor blocker (ARB) (losartan) due to a persistent cough. How would this change in medication be expected to affect the circulating levels of renin, angiotensin I, and angiotensin II?
Answer: Angiotensin II, angiotensin I, and renin levels will all increase.
The correct answer is B. ARBs block the AT1 receptor, preventing angiotensin II from exerting its effects, including negative feedback on renin release. The loss of this negative feedback loop leads to a compensatory increase in plasma renin activity. Increased renin leads to increased production of angiotensin I, and subsequently, increased conversion to angiotensin II (since ACE is not inhibited). Thus, levels of all three components (renin, Ang I, and Ang II) increase, although the effects of Ang II are blocked at the receptor level.
- What is the expected effect of this drug on the levels of plasma renin activity (PRA), angiotensin I, and angiotensin II?
Answer: PRA decreased, Angiotensin I decreased, Angiotensin II decreased.
The correct answer is A. Aliskiren is a direct renin inhibitor. It binds to the active site of renin and prevents it from cleaving angiotensinogen to form angiotensin I. This blocks the very first and rate-limiting step of the RAAS cascade. Consequently, plasma renin activity (PRA), which measures the rate of angiotensin I generation, will decrease. Since less angiotensin I is formed, levels of angiotensin II will also decrease. Note: While plasma renin concentration might increase due to loss of negative feedback, the question asks for plasma renin activity, which is inhibited by the drug.
- What is the most likely mechanism for the NSAID-induced acute kidney injury in this patient?
Answer: Combined afferent arteriole constriction and efferent arteriole dilation, severely reducing glomerular pressure.
The correct answer is C. In a low-flow state like heart failure, GFR is maintained by two key mechanisms: 1) Prostaglandins dilate the afferent arteriole to maintain blood flow into the glomerulus, and 2) Angiotensin II constricts the efferent arteriole to maintain pressure within the glomerulus. This patient is on an ACE inhibitor, which blocks angiotensin II, thus dilating the efferent arteriole. The addition of an NSAID blocks prostaglandin synthesis, leading to constriction of the afferent arteriole. The combination of afferent constriction and efferent dilation causes a precipitous drop in intraglomerular hydrostatic pressure, leading to a sharp decline in GFR and acute kidney injury.
- Which of the following scenarios would lead to the lowest rate of renin secretion from the juxtaglomerular cells?
Answer: A patient with primary hyperaldosteronism (Conn's syndrome).
The correct answer is C. Renin secretion is inhibited by high blood pressure at the afferent arteriole, high sodium delivery to the macula densa, and negative feedback from angiotensin II. In primary hyperaldosteronism, an adrenal tumor autonomously secretes aldosterone, leading to significant sodium and water retention. This causes volume expansion and hypertension. The combination of high renal perfusion pressure and increased sodium delivery to the distal nephron provides a powerful inhibitory signal to the juxtaglomerular cells, leading to profound suppression of renin secretion.
- Which set of electrolyte and acid-base abnormalities is most consistent with the pathophysiology of this patient's condition?
Answer: Hyponatremia, hyperkalemia, and a non-anion gap metabolic acidosis.
The correct answer is A. Primary adrenal insufficiency involves the destruction of the adrenal cortex, leading to a deficiency of both cortisol and aldosterone. The lack of aldosterone impairs the function of the distal nephron, resulting in: 1) inability to reabsorb sodium, leading to volume depletion and hyponatremia; 2) inability to secrete potassium, leading to hyperkalemia; and 3) inability to secrete hydrogen ions, leading to a non-anion gap metabolic acidosis. The hypotension is due to both volume depletion (aldosterone deficiency) and loss of cortisol's permissive effect on catecholamines.
- The patient's clinical presentation is most likely caused by which of the following effects of her medication?
Answer: Reduced aldosterone secretion leading to impaired renal potassium excretion.
The correct answer is B. The patient's symptoms (weakness, paralysis) and ECG findings (peaked T waves, wide QRS) are classic for severe hyperkalemia. ACE inhibitors block the conversion of angiotensin I to angiotensin II. Reduced angiotensin II levels lead to decreased aldosterone secretion from the adrenal cortex. Since aldosterone's primary function is to promote potassium secretion in the distal nephron, its inhibition results in potassium retention and can lead to hyperkalemia, especially in patients with underlying renal impairment like diabetic nephropathy.
- The absence of severe edema in this patient is best explained by which physiological phenomenon?
Answer: The "aldosterone escape" mechanism, involving increased pressure natriuresis and ANP release.
The correct answer is B. In primary hyperaldosteronism, the initial aldosterone-driven sodium and water retention causes volume expansion and hypertension. This expansion increases renal perfusion pressure and stretches the cardiac atria, leading to pressure natriuresis and the release of Atrial Natriuretic Peptide (ANP). ANP promotes sodium and water excretion by increasing GFR and directly inhibiting sodium reabsorption in the collecting duct. This counter-regulatory response allows the kidney to "escape" the full sodium-retaining effect of aldosterone, establishing a new steady state with mild hypervolemia and hypertension but without progressive edema formation.
- What is the primary rationale for adding spironolactone to furosemide in this patient?
Answer: To counteract the secondary hyperaldosteronism that drives diuretic resistance and potassium wasting.
The correct answer is B. In cirrhosis, splanchnic vasodilation reduces effective circulating volume, leading to profound activation of the RAAS (secondary hyperaldosteronism). High levels of aldosterone drive intense sodium reabsorption in the distal nephron. While furosemide blocks sodium reabsorption in the loop of Henle, much of this sodium is reabsorbed downstream under the influence of aldosterone. This limits furosemide's efficacy (diuretic resistance) and exacerbates potassium secretion. Spironolactone, an aldosterone antagonist, directly blocks this downstream effect, enhancing natriuresis and conserving potassium.
